1623 Capital LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 136 filers reported holding CARDLYTICS INC in Q3 2022. The put-call ratio across all filers is 4.40 and the average weighting 0.4%.

Quarter-by-quarter ownership
1623 Capital LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2022$306,000
-57.9%
32,5760.0%0.19%
-58.3%
Q2 2022$727,000
+71.5%
32,576
+322.4%
0.45%
+113.7%
Q1 2022$424,000
-9.2%
7,713
+38.6%
0.21%
+16.5%
Q3 2021$467,000
-33.9%
5,5650.0%0.18%
-32.8%
Q2 2021$706,000
+67.3%
5,565
+44.7%
0.27%
+57.6%
Q1 2021$422,0003,8470.17%
Other shareholders
CARDLYTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders